(Q28342785)

https://api.crossref.org/works/10.3109/14756369209041357

23 November 2023

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

23 November 2023

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

23 November 2023

author name string

T. D. Meek

1

1 reference

Europe PubMed Central

PubMed publication ID

1285304

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1285304

full work available at URL

9 September 2022

language of work or name

English

0 references

publication date

1992

0 references

http://www.tandfonline.com/doi/pdf/10.3109/14756369209041357

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Journal of Enzyme Inhibition and Medicinal Chemistry

23 November 2023

published in

0 references

volume

6

0 references

issue

1

0 references

page(s)

65-98

0 references

cites work

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

2

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

23 November 2023

3

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Strategies for antiviral therapy in AIDS.

23 November 2023

4

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

23 November 2023

5

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

23 November 2023

6

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

23 November 2023

7

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

23 November 2023

8

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Molecular targets for AIDS therapy

23 November 2023

9

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Complete nucleotide sequence of the AIDS virus, HTLV-III

23 November 2023

11

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

23 November 2023

12

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Nucleotide sequence of the AIDS virus, LAV

23 November 2023

13

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

23 November 2023

14

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Genome organization and transactivation of the human immunodeficiency virus type 2.

23 November 2023

15

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

23 November 2023

16

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III

23 November 2023

18

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

23 November 2023

19

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule

23 November 2023

20

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

23 November 2023

21

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

23 November 2023

23

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

23 November 2023

24

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

The trans-activator gene of HTLV-III is essential for virus replication

23 November 2023

25

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

A second post-transcriptional trans-activator gene required for HTLV-III replication

23 November 2023

26

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

23 November 2023

27

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Fatty acylation of proteins

23 November 2023

29

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

23 November 2023

Viral proteinases

30

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Characterization of ribosomal frameshifting in HIV-1 gag-pol expression

23 November 2023

34

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15.

23 November 2023

36

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

23 November 2023

39

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus.

23 November 2023

41

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Recombinant HIV-1 reverse transcriptase: purification, primary structure, and polymerase/ribonuclease H activities

23 November 2023

42

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus

23 November 2023

43

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1

23 November 2023

45

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus

23 November 2023

46

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity

23 November 2023

48

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Active human immunodeficiency virus protease is required for viral infectivity

23 November 2023

49

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.

23 November 2023

50

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

The preparation and biochemical characterization of intact capsids of equine infectious anemia virus

23 November 2023

51

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Defectiveness of avian erythroblastosis virus: synthesis of a 75K gag-related protein

23 November 2023

52

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Retroviral protease-like sequence in the yeast transposon Ty 1

23 November 2023

56

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor

23 November 2023

58

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli

23 November 2023

59

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity

23 November 2023

60

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli

23 November 2023

61

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody.

23 November 2023

62

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

In vivo and in vitro autoprocessing of human immunodeficiency virus protease expressed in Escherichia coli

23 November 2023

63

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli.

23 November 2023

64

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A

23 November 2023

65

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

High-level expression of self-processed HIV-1 protease in Escherichia coli using a synthetic gene

23 November 2023

67

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Chemical synthesis and expression of the HIV-1 protease gene in E. coli

23 November 2023

68

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

HTLV-III gag protein is processed in yeast cells by the virus pol-protease

23 November 2023

69

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Recombinant HIV1 protease secreted by Saccharomyces cerevisiae correctly processes myristylated gag polyprotein.

23 November 2023

71

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli

23 November 2023

72

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease

23 November 2023

73

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Chemical synthesis and enzymatic activity of a 99-residue peptide with a sequence proposed for the human immunodeficiency virus protease

23 November 2023

74

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Genetic locus, primary structure, and chemical synthesis of human immunodeficiency virus protease

23 November 2023

75

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

A structural model for the retroviral proteases.

23 November 2023

76

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease

23 November 2023

77

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

23 November 2023

78

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes

23 November 2023

79

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease

23 November 2023

80

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Molecular modeling of the HIV-1 protease and its substrate binding site

23 November 2023

81

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Crystal structure of a retroviral protease proves relationship to aspartic protease family

23 November 2023

82

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Mechanism of acid protease catalysis based on the crystal structure of penicillopepsin

23 November 2023

83

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Penicillopepsin: 2.8 a Structure, Active Site Conformation and Mechanistic Implications

23 November 2023

84

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

X-Ray Analysis and Circular Dichroism of the Acid Protease from Endothia Parasitica and Chymosin

23 November 2023

85

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

The Crystal Structure of an Acid Protease from Rhizopus Chinensis at 2.5 a Resolution

23 November 2023

86

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Homology among acid proteases: comparison of crystal structures at 3A resolution of acid proteases from Rhizopus chinensis and Endothia parasitica

23 November 2023

87

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Structure and refinement of penicillopepsin at 1.8 Å resolution

23 November 2023

88

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution

23 November 2023

89

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

23 November 2023

90

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor

23 November 2023

91

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor

23 November 2023

92

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

23 November 2023

Renin inhibitors

94

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins

23 November 2023

95

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Peptide substrates and inhibitors of the HIV-1 protease

23 November 2023

97

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides

23 November 2023

98

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases

23 November 2023

99

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1.

23 November 2023

100

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases

23 November 2023

101

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease

23 November 2023

102

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Studies on the mechanisms of action of proteolytic enzymes using heavy oxygen exchange

23 November 2023

103

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Three-dimensional structure of the complex of the Rhizopus chinensis carboxyl proteinase and pepstatin at 2.5-A resolution

23 November 2023

104

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Stereochemical analysis of peptide bond hydrolysis catalyzed by the aspartic proteinase penicillopepsin

23 November 2023

107

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analogue inhibitor

23 November 2023

108

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action

23 November 2023

109

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors

23 November 2023

110

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease

23 November 2023

111

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism

23 November 2023

114

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin

23 November 2023

122

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Fluoro ketone inhibitors of hydrolytic enzymes

23 November 2023

124

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Potent new inhibitors of human renin

23 November 2023

125

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Human renin: a new class of inhibitors.

23 November 2023

127

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

23 November 2023

128

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres

23 November 2023

129

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

23 November 2023

131

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

L-687,908, a potent hydroxyethylene-containing HIV protease inhibitor

23 November 2023

132

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Proceedings of the National Academy of Sciences of the United States of America

23 November 2023

133

81

1412

Ashorn P.

1990

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Design and conformational analysis of several highly potent bradykinin receptor antagonists

23 November 2023

134

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Phosphorus-containing peptide analogs as peptidase inhibitors.

23 November 2023

135

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus

23 November 2023

136

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Potent HIV-1 protease inhibitors with antiviral activities in vitro

23 November 2023

137

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Structure-based, C2 symmetric inhibitors of HIV protease

23 November 2023

138

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Rational design of peptide-based HIV proteinase inhibitors

23 November 2023

140

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease

23 November 2023

141

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

L-687,908, a potent hydroxyethylene-containing HIV protease inhibitor

23 November 2023

142

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

The chronically infected cell as a target for the treatment of HIV infection and AIDS.

23 November 2023

143

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

23 November 2023

144

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

In vitro inhibition of HIV-1 proteinase by cerulenin

23 November 2023

146

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Synthetic non-peptide inhibitors of HIV protease

23 November 2023

147

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin

23 November 2023

148

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease

23 November 2023

149

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4

23 November 2023

150

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines

23 November 2023

151

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Mapping the active site of papain with the aid of peptide substrates and inhibitors

23 November 2023

152

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

Standardized and simplified nomenclature for proteins common to all retroviruses

23 November 2023

153

1 reference

https://api.crossref.org/works/10.3109/14756369209041357

23 November 2023

Identifiers

1 reference

National Center for Biotechnology Information

PubMed publication ID

1285304